Success Metrics

Clinical Success Rate
40.0%

Based on 2 completed trials

Completion Rate
40%(2/5)
Active Trials
3(30%)
Results Posted
100%(2 trials)
Terminated
3(30%)

Phase Distribution

Ph not_applicable
6
60%
Ph phase_4
2
20%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(2)
Terminated(3)
Other(1)

Detailed Status

Terminated3
Completed2
Recruiting2
Not yet recruiting1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
40.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (25.0%)
N/A6 (75.0%)

Trials by Status

not_yet_recruiting110%
completed220%
unknown110%
active_not_recruiting110%
terminated330%
recruiting220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DEVICE
Total Trials
10